Fused imidazolyl derivatives, their preparation and use as medicaments
Abstract:
The present invention relates to new fused imidazolyl derivatives having a high affinity for sigma receptors, especially sigma-1 receptors, as well as to the process for the preparation thereof, to compositions comprising them, and to their use as medicaments.
Information query
Patent Agency Ranking
0/0